A detailed history of Gofen & Glossberg LLC transactions in Insulet Corp stock. As of the latest transaction made, Gofen & Glossberg LLC holds 800 shares of PODD stock, worth $212,544. This represents 0.01% of its overall portfolio holdings.

Number of Shares
800
Holding current value
$212,544
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 13, 2023

BUY
$212.22 - $313.46 $169,776 - $250,767
800 New
800 $236,000
Q2 2022

Jul 14, 2022

SELL
$186.4 - $279.02 $149,120 - $223,216
-800 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$194.8 - $275.7 $1,363 - $1,929
-7 Reduced 0.87%
800 $213,000
Q4 2021

Jan 25, 2022

BUY
$255.32 - $318.29 $1,787 - $2,228
7 Added 0.88%
807 $215,000
Q4 2020

Jan 15, 2021

BUY
$215.97 - $265.89 $172,776 - $212,712
800 New
800 $205,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.4B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Gofen & Glossberg LLC Portfolio

Follow Gofen & Glossberg LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.